Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06465056
PHASE2

Use of Botulinum Toxin A in Direct Eyebrow Lift Scar

Sponsor: University of Sao Paulo

View on ClinicalTrials.gov

Summary

Prospective, controlled and randomized study in which participants indicated for surgery to direct eyebrow lift will be randomized into two groups. In addition to surgery, the patients will be treated with botulinum toxin in one eyebrow and saline (placebo) in the other site. The patients participate as treatment and placebo at the same time. Assessments will be carried out through non-invasive exams.

Official title: Use of Botulinum Toxin A in Direct Eyebrow Lift Scar: a Randomized Controlled Clinical Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2024-01-01

Completion Date

2026-01-01

Last Updated

2024-06-18

Healthy Volunteers

Yes

Interventions

DRUG

Botulinum toxin type A

Botulinum toxin application between 3-14 days after direct eyebrow lift surgery.

Locations (2)

University of São Paulo (Clinical Hospital)

São Paulo, Brazil

Ophthalmology Dept. University of Sao Paulo General Hospital

São Paulo, Brazil